[18F]Fluorodeoxyglucose Positron Emission Tomography in the Initial Staging of Squamous Cell Carcinoma of the Head and Neck: Promise, Evidence, and Reality

Positron Emission Tomography With [18F]Fluorodeoxyglucose Improves Staging and Patient Management in Patients With Head and Neck Squamous Cell Carcinoma: A Multicenter Prospective Study

(2010) Max Lonneux et al.   JOURNAL OF CLINICAL ONCOLOGY

Chest CT and Whole-Body 18F-FDG PET Are Cost-Effective in Screening for Distant Metastases in Head and Neck Cancer Patients

(2010) C. A. Uyl-de Groot et al.   JOURNAL OF NUCLEAR MEDICINE

Cancer Statistics, 2009

(2009) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Prospective Risk-Adjusted [18F]Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography Assessment of Radiation Response in Head and Neck Cancer

(2009) Benjamin J. Moeller et al.   JOURNAL OF CLINICAL ONCOLOGY

PET and PET/CT Reports: Observations from the National Oncologic PET Registry

(2009) R. E. Coleman et al.   JOURNAL OF NUCLEAR MEDICINE

Screening for distant metastases in head and neck cancer patients by chest CT or whole body FDG-PET: A prospective multicenter trial

(2008) Asaf Senft et al.   RADIOTHERAPY AND ONCOLOGY